AO-176 in Multiple Solid Tumor Malignancies

计划入组 57 人 · 首次发布于 2019 年 2 月 8 日

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

计划入组 27 人 · 首次发布于 2020 年 7 月 14 日

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

计划入组 141 人 · 首次发布于 2016 年 2 月 5 日

ELB-176

SOL-176

C-176

Children's Hospital Medical Center of Akron

United States

Charleston Laboratories, Inc.

United States

Synthonics, Inc.

United States

Bruce Power Wins Regulatory Approval to Process Cancer-Fighting Lutetium-177 On-Site

ASP Isotopes and Isotopia Forge Strategic Partnership to Accelerate Terbium-161 Cancer Therapy Production

SHINE Technologies Secures European Marketing Authorization for Lutetium-177 Radioisotope Ilumira